 |
FDA Approval Activities for this Drug
NicoDerm CQ (nicotine transdermal system) clear and opaque, 21mg, 14mg, and 7 mg GlaxoSmithKline Consumer Healthcare NDA 20-165/S-020 8/13/02 8/14/02
Nicorette Gum, 4 mg SmithKline Beecham Consumer Healthcare NDA 20-066/S10 9/25/00 5/1/02 5/1/02 5/1/02
Nicorette (Nicotine Polacrilex) Gum, 2 & 4 mg SmithKline Beecham Consumer Healthcare NDA 18-612/S031 & 20-066/S13 8/9/02 8/12/02
Nicorette 2 & 4 mg (Nicotine Polacrilex) Gum, SmithKline Beecham Consumer Healthcare NDA 18-612/S025 & 20-066/S7 12/23/1998 5/1/02 5/1/02 5/1/02
Nicotine Polacrilex Gum USP, 2 mg (base) Circa NDA 74-507 3/15/99 3/16/99 4/23/03
Nicotine Polacrilex Gum USP, 4 mg (base). Circa NDA 74-707 3/19/99 3/22/99 4/22/03
Nicotrol Inhaler (nicotine inhalation system), Pharmacia Consumer HealthCare NDA 20-714/S-010 9/8/02 9/11/02
Nicotrol Patch (nicotine transdermal system), 15 mg Pharmacia and Upjohn Company NDA 20-536/S-010 7/23/02 7/24/02
Nicotrol NS (nicotine nasal spray), Pharmacia Consumer Healthcare NDA 20-385/S-005 9/8/02 9/11/02
Nicotrol TD (nicotine transdermal system), Pharmacia Consumer Healthcare NDA 20-150/S-011 ProStep (nicotine transdermal system), 11 mg/day and 22 mg/day patches Elan Drug Delivery, NDA 19-983/S17 10/4/02 10/11/01
ProStep (nicotine transdermal system), 11 mg/day and 22 mg/day patches Elan Pharmaceutical Research NDA 19-983/S16 1/18/02 2/5/02 2/5/02
ProStep (nicotine transdermal system), 11 mg/day and 22 mg/day patches Elan Pharmaceutical Research NDA 19-983/S-012 12/23/98 1/6/99 7/13/00
ProStep Indication: Aid to stop smoking cigarettes (for those over 18 years of age). Nicotrol NS & Inhaler, Pharmacia Consumer Healthcare Habitrol (nicotine) Transdermal System, Novartis Consumer Health, Inc. Habitrol (nicotine) Transdermal System, Novartis Consumer Commit (nicotine polacrilex) Lozenge, GlaxoSmithKline Nicorette (Nicotine Polacrilex) Gum 2mg, GlaxoSmithKline
Nicorette Gum 4mg, GlaxoSmithKline
Nicotine 074611 NICOTINE FILM, EXTENDED RELEASE; TRANSDERMAL 14MG/24HR NICOTINE SANO
074612 NICOTINE FILM, EXTENDED RELEASE; TRANSDERMAL 21MG/24HR NICOTINE SANO
074645 NICOTINE FILM, EXTENDED RELEASE; TRANSDERMAL 7MG/24HR NICOTINE SANO
020714 NICOTINE INHALANT; ORAL 4MG/CARTRIDGE NICOTROL PHARMACIA AND UPJOHN
020385 NICOTINE SPRAY, METERED; NASAL 0.5MG/SPRAY NICOTROL PHARMACIA AND UPJOHN
Habitrol (nicotine) Transdermal System, Novartis Consumer Health, Inc.
Habitrol (nicotine) Transdermal System, Novartis Consumer
Nicorette (Nicotine Polacrilex) Gum 2mg, GlaxoSmithKline
Nicorette Gum 4mg, GlaxoSmithKline
Commit (nicotine polacrilex) Lozenge, GlaxoSmithKline
Nicorette (2 mg nicotine polacrilex) gum, GlaxoSmithKline
Nicorette (4 mg nicotine polacrilex) gum, GlaxoSmithKline Nicorette (2 mg nicotine polacrilex) gum, GlaxoSmithKline
Nicorette (4 mg nicotine polacrilex) gum, GlaxoSmithKline Nicotine Polacriles Gum (2mg), Watson Laboratories, Approval
Nicotine Polacriles Gum (4mg), Watson Laboratories, Approval | Nicotine Polacrilex Gum (2mg Mint), L. Perrigo Co., Approval
| Nicotine Polacrilex Gum (2mg Orange), L. Perrigo Co., Approval
| Nicotine Polacrilex Gum (2mg Regular), L. Perrigo Co., Approval
| Nicotine Polacrilex Gum (4mg Mint), L. Perrigo Co., Approval
| Nicotine Polacrilex Gum (4mg Orange), L. Perrigo Co., Approval
| Nicotine Polacrilex Gum (4mg Regular), L. Perrigo Co., Approval | Habitrol (nicotine transdermal system), Novartis, Package Change
For the most up-to-date approval information, please locate this API using the drug index.
|